Bicycle Therapeutics plc Increase Decrease In Operating Lease Liability
Bicycle Therapeutics plc (BCYC) reported Increase Decrease In Operating Lease Liability of -$1.99 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-07-30
- Bicycle Therapeutics plc increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$711.00K.
- Bicycle Therapeutics plc increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$1.28M.
- Bicycle Therapeutics plc increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$1.41M.
- Bicycle Therapeutics plc increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$1.39M.
- Bicycle Therapeutics plc increase decrease in operating lease liability for fiscal 2025 was -$5.46M.
- Bicycle Therapeutics plc increase decrease in operating lease liability for fiscal 2024 was -$4.89M.
- Bicycle Therapeutics plc increase decrease in operating lease liability for fiscal 2023 was -$4.11M.
- Bicycle Therapeutics plc increase decrease in operating lease liability for fiscal 2022 was -$2.11M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$711.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$1.99M 10-Q · filed 2026-07-30 | -$3.40M derived: sum of 3 quarters · filed 2026-07-30 | -$4.79M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | -$1.28M 10-Q · filed 2026-04-30 | -$2.69M derived: sum of 2 quarters · filed 2026-04-30 | -$4.08M derived: sum of 3 quarters · filed 2026-04-30 | -$5.44M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | -$1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$2.80M derived: sum of 2 quarters · filed 2026-03-17 | -$4.16M derived: sum of 3 quarters · filed 2026-07-30 | -$5.46M 10-K · filed 2026-03-17 |
| 2025-09-30 | -$1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$2.75M derived: sum of 2 quarters · filed 2026-07-30 | -$4.05M 10-Q · filed 2025-10-30 | -$5.31M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | -$1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$2.66M 10-Q · filed 2026-07-30 | -$3.92M derived: sum of 3 quarters · filed 2026-07-30 | -$5.16M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | -$1.29M 10-Q · filed 2026-04-30 | -$2.56M derived: sum of 2 quarters · filed 2026-04-30 | -$3.80M derived: sum of 3 quarters · filed 2026-04-30 | -$5.00M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | -$1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$2.51M derived: sum of 2 quarters · filed 2026-03-17 | -$3.71M derived: sum of 3 quarters · filed 2026-03-17 | -$4.89M 10-K · filed 2026-03-17 |
| 2024-09-30 | -$1.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$2.45M derived: sum of 2 quarters · filed 2025-10-30 | -$3.63M 10-Q · filed 2025-10-30 | -$4.75M derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-06-30 | -$1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$2.38M 10-Q · filed 2025-08-08 | -$3.51M derived: sum of 3 quarters · filed 2026-03-17 | -$4.62M derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-03-31 | -$1.18M 10-Q · filed 2025-05-01 | -$2.31M derived: sum of 2 quarters · filed 2026-03-17 | -$3.42M derived: sum of 3 quarters · filed 2026-03-17 | -$4.25M derived: sum of 4 quarters · filed 2026-03-17 |
| 2023-12-31 | -$1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$2.24M derived: sum of 2 quarters · filed 2026-03-17 | -$3.08M derived: sum of 3 quarters · filed 2026-03-17 | -$4.11M 10-K · filed 2026-03-17 |
| 2023-09-30 | -$1.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$1.95M derived: sum of 2 quarters · filed 2024-10-31 | -$2.98M 10-Q · filed 2024-10-31 | -$3.65M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | -$833.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$1.87M 10-Q · filed 2024-08-06 | -$2.54M derived: sum of 3 quarters · filed 2025-02-25 | -$3.19M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | -$1.03M 10-Q · filed 2024-05-02 | -$1.70M derived: sum of 2 quarters · filed 2025-02-25 | -$2.36M derived: sum of 3 quarters · filed 2025-02-25 | -$3.04M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | -$668.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$1.32M derived: sum of 2 quarters · filed 2025-02-25 | -$2.01M derived: sum of 3 quarters · filed 2025-02-25 | -$2.11M 10-K · filed 2025-02-25 |
| 2022-09-30 | -$657.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$1.34M derived: sum of 2 quarters · filed 2023-11-02 | -$1.45M 10-Q · filed 2023-11-02 | -$4.15M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | -$684.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$789.00K 10-Q · filed 2023-08-03 | -$3.49M derived: sum of 3 quarters · filed 2024-02-20 | -$3.67M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | -$105.00K 10-Q · filed 2023-05-04 | -$2.81M derived: sum of 2 quarters · filed 2024-02-20 | -$2.98M derived: sum of 3 quarters · filed 2024-02-20 | -$3.15M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | -$2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | -$2.88M derived: sum of 2 quarters · filed 2024-02-20 | -$3.05M derived: sum of 3 quarters · filed 2024-02-20 | -$582.00K 10-K · filed 2024-02-20 |
| 2021-09-30 | -$173.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$343.00K derived: sum of 2 quarters · filed 2022-11-03 | $2.12M 10-Q · filed 2022-11-03 | $1.70M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$170.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $2.30M 10-Q · filed 2022-08-04 | $1.87M derived: sum of 3 quarters · filed 2023-02-28 | $1.67M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $2.47M 10-Q · filed 2022-05-05 | $2.04M derived: sum of 2 quarters · filed 2023-02-28 | $1.84M derived: sum of 3 quarters · filed 2023-02-28 | |
| 2020-12-31 | -$428.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$625.00K derived: sum of 2 quarters · filed 2023-02-28 | -$621.00K 10-K · filed 2023-02-28 | |
| 2020-09-30 | -$197.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$193.00K 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $4.00K 10-Q · filed 2021-08-05 | |||
| 2019-12-31 | -$709.00K 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |